Download PDF
Thromb Haemost 1978; 39(03): 733-742
DOI: 10.1055/s-0038-1646750
Original Article
Schattauer GmbH Stuttgart

Thrombocytopenia Induced in Mice by Thromboplastin Infusion – Essential Role of the Third Complement Component

Luis A Giraudo
The University of Minnesota Medical School, Department of Laboratory Medicine and Pathology, Veterans Administration Hospital, Minneapolis, Minnesota 55417, U.S.A.
,
Agustin P Dalmasso
The University of Minnesota Medical School, Department of Laboratory Medicine and Pathology, Veterans Administration Hospital, Minneapolis, Minnesota 55417, U.S.A.
› Author Affiliations
Further Information

Publication History

Received 24 August 1977

Accepted 04 November 1977

Publication Date:
12 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

Studies were performed in mice to investigate the effects of the slow infusion of brain thromboplastin (tissue factor) on blood platelet levels. Thromboplastin caused pronounced thrombocytopenia in all strains of mice tested without histological evidence of intravascular coagulation. The role of the complement system in the thrombocytopenic response to thromboplastin administration was evaluated by using complement-deficient animals. Depending on experimental conditions, the degree of platelet reduction in C5-deficient mice was similar to or significantly lower than in normocomplementemic animals. C5-deficient mice reconstituted with mouse plasma or purified human C5 had a thrombocytopenic reaction identical to that of normocomplementemic controls. The thrombocytopenic response of B10.D2/new and old line mice could be abrogated by inactivating C3 with cobra venom factor prior to the administration of thromboplastin. We conclude that in mice C3 plays a central role in the thrombocytopenia induced by thromboplastin infusion, while C5 (and/or other late acting components) plays only a minor role. In vivo activation of complement by thromboplastin was indicated by the finding that thromboplastin infusion in B10.D2/new mice caused a significant reduction in total serum hemolytic complement and a slight reduction in C3 measured immunochemically. The platelet counts of uninjected B10.D2/new mice were slightly but significantly higher than in B10.D2/old mice.

 

  • References

  • 1 Albrechtsen OK, Brakman P, Astrup T. 1970; The defibrination syndrome in rabbits following infusion of tissue thromboplastin in the jugular vein. Thrombosis et Diathesis Haemorrhagica 24: 113
    PubMedGoogle Scholar
  • 2 Ballow M, Cochrane CG. 1969; Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them. Journal of Immunology 103: 944
    PubMedGoogle Scholar
  • 3 Boyer JT, Gall EP, Norman ME, Nilsson UR, Zimmerman TS. 1975; Hereditary deficiency of the seventh component of complement. Journal of Clinical Investigation 56: 905
    CrossrefPubMedGoogle Scholar
  • 4 Branson HE, Wyatt LL, Schmer G. 1976; Complement consumption in acute disseminated intravascular coagulation without antecedent immunopathology. American Journal of Clinical Pathology 66: 967
    CrossrefPubMedGoogle Scholar
  • 5 Brecher G, Cronkite EP. 1950; Morphology and enumeration of human blood platelets. Journal of Applied Physiology 3: 365
    CrossrefPubMedGoogle Scholar
  • 6 Breckenridge RT, Rosenfeld SI, Graff KS, Leddy JP. 1977; Hereditary C5 deficiency in man. III. Studies of hemostasis and platelet responses to zymosan. Journal of Immunology 118: 12
    PubMedGoogle Scholar
  • 7 Brown DL. 1975; Complement and coagulation. British Journal of Haematology 30: 377
    CrossrefPubMedGoogle Scholar
  • 8 Cinader B, Dubiski S, Wardlaw AC. 1964; Distribution, inheritance, and properties of an antigen, MuBl, and its relation to hemolytic complement. Journal of Experimental Medicine 120: 897
    CrossrefPubMedGoogle Scholar
  • 9 Cochrane CG, Müller-Eberhard HJ, Aikin BS. 1970; Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions. Journal of Immunology 105: 55
    PubMedGoogle Scholar
  • 10 Dalmasso AP, Lee M, Giraudo L, Swaim WR. 1973; Participation of complement in an experimental model of intravascular coagulation. Journal of Immunology 111: 298
    PubMedGoogle Scholar
  • 11 Gomberts ED, Rabson AR. 1977; Coagulation studies in a patient with homozygous C3 deficiency. British Journal of Haematology 35: 165
    CrossrefPubMedGoogle Scholar
  • 12 Grossklaus C, Damerau B, Lemgo E, Vogt W. 1976; Induction of platelet aggregation by the complement-derived peptides C3a and C5a. Naunyn-Schmiedeberg–s Archives of Pharmacology 295: 71
    PubMedGoogle Scholar
  • 13 Henson PM. 1969; The adherence of leukocytes and platelets induced by fixed IgG antibody or complement. Immunology 16: 107
    PubMedGoogle Scholar
  • 14 Heusinkveld RS, Leddy JP, Klemperer MR, Breckenridge RT. 1974; Hereditary deficiency of the sixth component of complement in man. II. Studies of hemostasis. Journal of Clinical Investigation 53: 554
    CrossrefPubMedGoogle Scholar
  • 15 Jarvinen JA, Dalmasso AP. 1977; Trypanosoma musculi infections in normocomplementemic, C5-deficient and C3-depleted mice. Infection and Immunity 16: 557
    PubMedGoogle Scholar
  • 16 Kalowski S, Howes Jr EL, Margaretten W, Mckay DG. 1975; Effects of intravascular clotting on the activation of the complement system: the role of the platelet. American Journal of Pathology 78: 525
    PubMedGoogle Scholar
  • 17 Lee ML, Lee MY, Dalmasso AP, Swaim WR. 1974; Abnormal platelet response to thromboplastin infusion in rabbits deficient in the sixth component of complement. Proceedings of the Society for Experimental Biology and Medicine 146: 732
    PubMedGoogle Scholar
  • 18 Mardiney MR, Müller-Eberhard HJ. 1965; Mouse βlc-globulin: production of antiserum and characterization in the complement reaction. Journal of Immunology 94: 877
    PubMedGoogle Scholar
  • 19 Monkhouse FC, Milojevic S. 1960; Changes in fibrinogen level after infusion of thrombin and thromboplastin. American Journal of Physiology 199: 1165
    PubMedGoogle Scholar
  • 20 Nilsson UR, Müller-Eberhard HJ. 1967; Deficiency of the fifth component of complement in mice with an inherited complement defect. Journal of Experimental Medicine 125: 1
    CrossrefPubMedGoogle Scholar
  • 21 Nilsson UR, Tomar RH, Taylor Jr FB. 1972; Additional studies on human C5 : Development of a modified purification method and characterization of the purified product by polyacrylamide gel electrophoresis. Immunochemistry 9: 709
    CrossrefPubMedGoogle Scholar
  • 22 Owen Jr CA, Bowie EJW, Thompson Jr JH. 1975. Thediagnosisofbleedingdisorders. 2nd edn Little, Brown, and Co; Boston: 112
    Google Scholar
  • 23 Pfueller SL, LüScher EF. 1974; Studies of the mechanisms of the human platelet release reaction induced by immunologic stimuli. II. The effects of zymosan. Journal of Immunology 112: 1211
    PubMedGoogle Scholar
  • 24 Pitlick FA, Nemerson Y. 1970; Binding of the protein component of tissue factor to phospholipids. Biochemistry 9: 5105
    CrossrefPubMedGoogle Scholar
  • 25 Quick AJ. 1957. Hemorrhagic Diseases. Lea & Febiger; Philadelphia: 380
    Google Scholar
  • 26 Ratnoff OD. 1969; Some relationships among hemostasis, fibrinolytic phenomena, immunity, and the inflammatory response. Advances in Immunology 10: 145
    PubMedGoogle Scholar
  • 27 Simmons WH, Burkholder DE, Brecher AS. 1976; The hydrolysis of biologically active peptides by bovine lung tissue factor (thromboplastin). Proceedings of the Society for Experimental Biology and Medicine 152: 576
    PubMedGoogle Scholar
  • 28 Siraganian RP. 1972; Platelet requirement in the interaction of the complement and clotting systems. Nature (New Biology) 239: 208
    CrossrefPubMedGoogle Scholar
  • 29 Sullivan Jr JD, Watson SW. 1974; Factors affecting the sensitivity of Limulus lysate. Applied Microbiology 28: 1023
    PubMedGoogle Scholar
  • 30 Terry WD, Borsos T, Rapp HJ. 1964; Differences in serum complement activity among inbred strains of mice. Journal of Immunology 92: 576
    PubMedGoogle Scholar
  • 31 Tomar RH, Kolchins D. 1972; Complement and coagulation. Serum βlc–βla in disseminated intravascular coagulation. Thrombosis et Diathesis Haemorrhagica 27: 389
    PubMedGoogle Scholar
  • 32 Zeldis SM, Nemerson Y, Pitlick FA, Lentz TL. 1972; Tissue factor (thromboplastin): localization to plasma membranes by peroxidase-conjugated antibodies. Science 175: 766
    CrossrefPubMedGoogle Scholar
  • 33 Zimmerman TS, Arroyave CM, Müller-Eberhard HJ. 1971; A blood coagulation abnormality in rabbits deficient in the sixth component of complement (C6) and its correction by purified C6. Journal of Experimental Medicine 134: 1591
    CrossrefPubMedGoogle Scholar
  • 34 Zucker MB, Grant RA, Alper CA, Goodkofsky I, Lepow IH. 1974; Requirement for complement components and fibrinogen in the zymosan-induced release reaction of human blood platelets. Journal of Immunology 113: 1744
    PubMedGoogle Scholar